Zhitong Finance App News, Yuanda Pharmaceutical (00512.HK) issued an announcement. In order to support the Group's overseas expansion strategy, the board of directors believes that now is the right time to rotate the company's external auditors. In accordance with the recommendation of the Board of Directors Audit Committee, the Company intends to terminate the appointment of the Company's current auditor Guowei Certified Public Accountants Limited (Guowei) as the Company's auditor for the year ended December 31, 2026 (proposed termination), and appoint Deloitte • Guanhuang Chen Fang (Deloitte) as the Company's new auditor for the year ended December 31, 2026 to fill the temporary vacancy caused by the “proposed termination” and hold office until the end of the next annual general meeting of shareholders of the Company (proposed appointment, together with “proposed termination”, collectively referred to as “proposed replacement” Teacher” ). The proposed change of auditor can only be implemented (including) after the special shareholders' meeting to be convened by the Company passes the relevant resolution.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.